Changelog

2024-11-20

• Added Boldenone Cypionate. No data is available, so we currently use the pharmacokinetic model from Testosterone Cypionate.
• Moved Equipose under Boldenone as “Undecylenate (Equipoise).”

2024-10-22

• Added option for every 15, 16, 17, 18, 19 and 20 days.

2024-10-17

• A new slider was added to adjust levels up or down by a specific percentage. This is useful if you know you respond differently to a particular compound so you can account for your individual variation.

2024-10-15

• Added option for every 11, 12, and 13 days.
• Testosterone cypionate and enanthate do not currently use the linear regression model due to issues at lower doses. This will be improved and reimplemented at a later date.

2024-10-13

• Fixed bug that showed levels too low with compounds using the simple model.

2024-10-10

• Compounds that use linear regression (currently Testosterone Cypionate and Enanthate) were inaccurate at lower doses typically used for female testosterone replacement. This has now been fixed, and these compounds should be accurate when plotted at lower weekly doses.

2024-09-20

• Added basic protocol summaries to shared protocols. These will be expanded upon in the future to include more details about compounds and their pharmacokinetics, along with sources.

2024-05-01

• Added a new tool. You can now convert between different testosterone units, such as Nmol/l to ng/dl or ng/dl to nmol/l.
• Added another tool to help users calculate their Free Testosterone levels.

2024-04-24

• Adjusted Testosterone Propionate to account for endogenous levels seen in the study.

2024-04-24

• Added Clenbuterol (Oral)

2024-04-22

• Added Dihydroboldenone (DHB)

2024-04-19

• Added options for dosing every 8 days and every 9 days.
• Added Injectable Estradiol (Cypionate)

2024-04-11

• Adjusted Testosterone Isocaproate (simplified model) multiplier to more closely match other testosterone esters that use the advanced model.

2024-03-28

• Fixed bug where offset compound would not show when using “Compare.”
• Updated Testosterone Undecanoate half-life to 33.9 days from a study using castor oil (previous half-life was from a study with unknown oil.) It now more closely matches values from Undecanoate (Nebido), so we may remove one of these versions at a later date.

2024-03-22

• We have created a more advanced model for compounds where blood levels don’t scale linearly with dosage. This model includes a linear regression equation that will result in a lower increase in cmax as the dose increases, mimicking the diminishing effect seen in some compounds. This model is used where clinical data is available to calculate the slope and intercept.

2024-03-19

• Added grouping to the dropdown lists of Anabolic Steroids/Hormones and Pharmaceuticals/Chemicals so users can more easily find the compound they are looking for.

2024-03-18

• Added Letrozole

2024-03-16

• Added Tadalafil (Cialis)

2024-03-15

• Added Test Base (Sublingual)
• Added option “Shared URL always reflects user’s current date.” Shared URLs will always start from the current day if this box is checked before sharing.
• Added “3 times per week” schedule. This defaults to days 1,3 and 5, so if your protocol starts on Monday, your doses will be on Monday, Wednesday, and Friday.

2024-03-14

• Added 4 times per day and 3 times per day dosing schedules.
• Added progesterone (oral and vaginal)
• Added T3 (Triiodothyronine)
• Added new SARMs compound type
• Added Ostarine (MK-2866 / Enobosarm)
• Added Ligandrol (LGD-4033)
• Added Andarine (S4)
• Added Testolone (RAD-140)
• Added Cardarine (GW-501516)
• Added S-23

2024-03-13

• Added Mesterolone (Proviron)
• Added Testosterone Gel (Testogel/Androgel)

2024-03-11

• Fixed bug which caused issues where matching compounds were not added sequentially.
• Now sanitizing user input.
• Fixed bug with offset.

2024-03-08

• Added Trenbolone Hexahydrobenzylcarbonate
• Added Testosterone Undecanoate (Nebido) with a longer half-life (53 days as per Bayer) than the existing Testosterone Undecanoate (21 days).
• Added Testosterone Undecanoate (Oral)
• Adjusted Testosterone Suspension so levels should be more in line with what is expected.
• Added Estradiol (EstroGel)

2024-02-20

• Improved pharmacokinetic model to include t_1/2 (half-life), C_max (peak concentration) & T_max (time at which C_max is observed) where available. Results (in ng/dL) should now be more accurate for some compounds.
• Fallback to second best model based on t_1/2, F(%) (bioavailability) + T_max
• Fallback to the final model, which estimates T_max based on half-life.
• Added multiplier to the model so compounds can be adjusted where levels do not meet expected real-world levels.

2024-02-07

• Initial Release